Scancell Holdings plc (AIM:SCLP)
London · Delayed Price · Currency is GBP · Price in GBX 12.62
+0.10 (0.76%)
Mar 5, 2026, 9:43 AM GMT
Scancell Holdings Market Cap
Scancell Holdings has a market cap or net worth of 129.98 million as of March 5, 2026. Its market cap has increased by 46.28% in one year.
Market Cap
129.98M
Enterprise Value
137.59M
Revenue
4.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.62
Market Cap Chart
Since June 29, 2009, Scancell Holdings's market cap has increased from 3.13M to 129.98M, an increase of 4,047.43%. That is a compound annual growth rate of 25.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 128.68M | 25.25% |
| Dec 31, 2025 | 102.74M | -6.96% |
| Dec 31, 2024 | 110.43M | 28.31% |
| Dec 29, 2023 | 86.06M | -57.34% |
| Dec 30, 2022 | 201.77M | 23.75% |
| Dec 31, 2021 | 163.04M | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PureTech Health | 298.88M |
| Avacta Group | 271.19M |
| 4basebio | 83.58M |
| Bioventix | 75.76M |
| Hemogenyx Pharmaceuticals | 62.33M |
| Faron Pharmaceuticals Oy | 59.05M |
| hVIVO | 54.77M |
| Ondine Biomedical | 53.25M |